Press Release

Glythera shortlisted for 2014 Biomedical Awards

2014 Biomedical Awards shortlist Sixteen companies have been shortlisted within five categories for the 2014 Biomedical Awards Ceremony. The event will celebrate the diversity of the companies within the North of England’s biomedical sector, and the strength and depth of the cluster. The winners of each award category will be announced at the ceremony taking place on Thursday 24 April 2014 at the BALTIC Centre for Contemporary Art on Gateshead Quays. The categories are Export Award – Sponsored by CBSL,…

Read more>>

Glythera makes Significant Appointments to Support Company Expansion

Glythera Set to Benefit From Nigel Burns and Ian Evetts Strategic Biotherapeutics Experience Newcastle-Upon-Tyne, UK (2 April, 2014) – Glythera, a biotechnology company specializing in the development of next generation bio-therapeutics, including Antibody Drug Conjugates,  through the application of its proprietary linker and stable glycan technologies PermaLink™ and PermaCarb™, is pleased to announce the appointment of Nigel Burns as Non-Executive Director and Ian Evetts as Commercial Director. Glythera has recently validated data from their core technologies and the addition of…

Read more>>

Glythera is now working with Newcastle Science City and the Environmental Academy to reduce its Environmental Impact

We are pleased to announce that Glythera is now working with Newcastle Science City and the Environmental Academy to reduce its Environmental Impact! Forming part of Newcastle Science City’s environmental sustainability initiative, the aim of the project is to help Glythera reduce its environmental impact whilst making significant financial savings. Sian Hepworth – Environmental consultant from the Environmental Academy is working with us to find the best environmental solutions for Glythera. Glythera will be environmentally responsible! Newcastle Science City is…

Read more>>